Effects of HIV Protease Inhibitors on Barrier Function in the Human Intestinal Cell Line HT-29/B6
Overview
Affiliations
Aspartyl Protease Inhibitors as Anti-Filarial Drugs.
Beld L, Jung H, Bulman C, Rosa B, Fischer P, Janetka J Pathogens. 2022; 11(6).
PMID: 35745561 PMC: 9227574. DOI: 10.3390/pathogens11060707.
Nathwani N, Palmer J, Synold T, Salehian B, Rosenzweig M, Sanchez J Clin Lymphoma Myeloma Leuk. 2020; 20(10):e667-e672.
PMID: 32631779 PMC: 7541704. DOI: 10.1016/j.clml.2020.05.017.
Rybakovsky E, Buleza N, Hoxha K, DiGuilio K, McCluskey E, Friday C Trends Cell Mol Biol. 2019; 13:99-114.
PMID: 31156296 PMC: 6542284.
Lei B, Zha W, Wang Y, Wen C, Studer E, Wang X Mol Pharm. 2010; 7(3):844-53.
PMID: 20349948 PMC: 2882528. DOI: 10.1021/mp100003r.
Wu X, Sun L, Zha W, Studer E, Gurley E, Chen L Gastroenterology. 2009; 138(1):197-209.
PMID: 19732776 PMC: 4644065. DOI: 10.1053/j.gastro.2009.08.054.